Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Title:
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Author:
Maher, Toby M Tudor, Veronica A Saunders, Peter Gibbons, Michael A Fletcher, Sophie V Denton, Christopher P Hoyles, Rachel K Parfrey, Helen Renzoni, Elisabetta A Kokosi, Maria Wells, Athol U Ashby, Deborah Szigeti, Matyas Molyneaux, Philip L
Appeared in:
Lancet respiratory medicine
Paging:
Volume 11 () nr. 1 pages 45-54
Year:
2023
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license